MarginsXMarginsX
Home › Markets › Health Care › MBOT

Microbot Medical Inc. (MBOT)

MBOT trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.6444
-34.16% on the day
Market cap
$43.3M
Nano cap
Revenue
No annual revenue filed since the period ending 2015-12-31
Net income
No annual revenue filed since the period ending 2015-12-31

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerMBOT on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryIsrael
IPO yearNot reported by the screener
SEC CIK0000883975
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials

No annual revenue filed since the period ending 2015-12-31.

Warning signs

Cash runway
2.1 months
$3.2M cash at June 30, 2026
Share count, 1 year
0.0%
2025-11-12 to 2026-11-12 · +473.7% over 3 years
Going-concern doubt
No
10-Q filed November 13, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-13
Cash and burn$3.2M cash; operating cash flow -$4.4M a quarter.Report 2026-06-30
Shares outstanding67,164,801 (2026-11-12); 67,158,044 a year earlier; 11,707,317 three years earlier.Cover page 2026-11-12
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the marketLatest 2026-04-10
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorBrightman Almagor Zohar & Co., Tel Aviv, IsraelPCAOB Form AP 2026-04-30
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$241K-$5.6M-$5.0M$3.2MNo debt tagsNeeds four quarters10-Q 2026-08-11
Q1 2026
2026-03-31
$105K-$3.7M-$5.1M$3.7MNo debt tagsNeeds four quarters10-Q 2026-05-13
Q4 2025
2025-12-31
Not filed-$3.5M-$3.8M$3.9MNo debt tagsNeeds four quarters10-K 2026-03-26
Q3 2025
2025-09-30
Not filed-$3.6M-$3.8M$6.7MNo debt tagsNeeds four quarters10-Q 2025-11-12
Q2 2025
2025-06-30
Not filed-$3.5M-$2.6M$4.1MNo debt tagsNeeds four quarters10-Q 2026-08-11
Q1 2025
2025-03-31
Not filed-$2.6M-$2.9M$3.2MNo debt tagsNeeds four quarters10-Q 2026-08-11
Q4 2024
2024-12-31
Not filed-$3.4M-$1.7M$3.1MNo debt tagsNeeds four quarters10-K 2026-03-26
Q3 2024
2024-09-30
Not filed-$3.2M-$2.8M$479KNo debt tagsNeeds four quarters10-Q 2025-11-12

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-04-10
Latest annual report10-K2026-03-26
Latest quarterly / interim10-Q2026-11-13
Latest current report8-K2026-11-16
Latest proxyDEFA14A2026-11-03

Source: SEC EDGAR submissions feed, 1,007 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-11.7%
1 month-3.9%
3 months-41.7%
Year to date-51.0%
1 year-50.8%
From 52-week high-65.6%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
ADGMAdagio Medical Holdings Inc$1.61-16.58%$44.2M
MDAISpectral AI Inc.$1.31+0.77%$42.2M
SRTSSensus Healthcare Inc.$2.34+0.65%$38.5M
DXRDaxor Corporation$8.36-0.89%$48.8M
TELATELA Bio Inc.$0.7616-7.13%$34.4M
NEPHNephros Inc.$3.00-1.64%$32.6M
XTNTXtant Medical Holdings Inc.$0.2098-22.78%$29.4M
QTEXQTREX Quantum Ltd.$1.15-8.00%$64.4M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier